Gyre Therapeutics
GYRE
#5556
Rank
NZ$1.79 B
Marketcap
$20.90
Share price
1.70%
Change (1 day)
-20.01%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.18

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.46. In 2023 the company made an earnings per share (EPS) of -$2.46 a decrease over its 2022 EPS that were of $0.007605.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.18-107.15%
2023-$2.46-32451.8%
2022$0.007605-90.93%
2021$0.08380